Marquette Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.2K Buy
140
+48
+52% +$10.3K ﹤0.01% 189
2026
Q1
$20K Sell
92
-200
-68% -$44.4K ﹤0.01% 160
2025
Q4
$66.7K Hold
292
0.01% 95
2025
Q3
$67.6K Sell
292
-152
-34% -$31K 0.01% 93
2025
Q2
$82.4K Hold
444
0.01% 74
2025
Q1
$93K Buy
444
+244
+122% +$47.4K 0.02% 77
2024
Q4
$35.5K Hold
200
0.01% 157
2024
Q3
$39.5K Buy
+200
New +$37.3K 0.01% 173
2022
Q4
Sell
-150
Closed -$20K 218
2022
Q3
$20K Hold
150
0.01% 174
2022
Q2
$23K Hold
150
0.01% 197
2022
Q1
$24K Hold
150
0.01% 227
2021
Q4
$20K Hold
150
﹤0.01% 229
2021
Q3
$16K Hold
150
﹤0.01% 228
2021
Q2
$17K Sell
150
-300
-67% -$33.8K ﹤0.01% 211
2021
Q1
$49K Hold
450
0.01% 160
2020
Q4
$48K Hold
450
0.01% 161
2020
Q3
$39K Hold
450
0.01% 150
2020
Q2
$44K Hold
450
0.01% 155
2020
Q1
$34K Buy
450
+300
+200% +$25.6K 0.01% 171
2019
Q4
$13K Hold
150
﹤0.01% 208
2019
Q3
$11K Buy
+150
New +$10.3K ﹤0.01% 238
2019
Q2
Sell
-121
Closed -$10K 253
2019
Q1
$10K Buy
+121
New +$9.9K ﹤0.01% 246

Other funds holding ABBV

Marquette Asset Management's ABBV Position: Q2 2026 in Review

Marquette Asset Management increased its AbbVie (ABBV) stake by 52% in Q2 2026, buying an estimated $10.3K and bringing the position to 140 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #189.

Marquette Asset Management first reported a position in ABBV in Q1 2019 and has held it in 22 quarters since. The position peaked at $93K in Q1 2025. 1,742 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Marquette Asset Management held 140 shares of AbbVie worth $35.2K as of Q2 2026.
  • Marquette Asset Management bought 48 AbbVie shares in Q2 2026, an estimated $10.3K.
  • AbbVie made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #189 holding.
  • Marquette Asset Management first reported a position in AbbVie in Q1 2019 and has held it in 22 quarters since.
  • Marquette Asset Management's AbbVie position peaked at $93K in Q1 2025.
  • 1,742 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.